<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03128177</url>
  </required_header>
  <id_info>
    <org_study_id>F150508004</org_study_id>
    <nct_id>NCT03128177</nct_id>
  </id_info>
  <brief_title>Nocturnal Hypertension and Non-Dipping Blood Pressure</brief_title>
  <official_title>Mechanisms of Nocturnal Hypertension and Non-Dipping Blood Pressure Patterns</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Heart Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if high salt diet contributes to high nighttime
      blood pressure. The investigators will determine if high compared to low salt diet increases
      24-hour blood pressure levels. The investigators will also determine if high salt diet
      affects blood vessel stiffness, cardiac output, and sleep apnea. The study will also
      determine how high salt diet affects the activity of certain genes related to control of
      blood pressure. A total of 60 participants will be enrolled in the study.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Anticipated">April 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Crossover study of high (6 g) and low (1.5 g) sodium diet</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Both the participant and investigator are blinded to the diet</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>24-hour blood pressure</measure>
    <time_frame>Baseline to 7 days after start of dietary period</time_frame>
    <description>Blood pressure measured by an ambulatory blood pressure monitor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Obstructive sleep apnea</measure>
    <time_frame>Baseline to 7 days after start of dietary period</time_frame>
    <description>Severity of obstructive sleep apnea as determine by the apnea hypopnea index</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hypertension</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>High sodium diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High sodium diet is 6 g sodium per day for 10 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low sodium diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low sodium diet is 1.5 g sodium per day for 10 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dietary sodium</intervention_name>
    <description>High (6 g) versus low (1.5 g) sodium diet</description>
    <arm_group_label>High sodium diet</arm_group_label>
    <arm_group_label>Low sodium diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Nocturnal hypertension

        Exclusion Criteria:

          -  Stage 2 clinic hypertension

          -  History of congestive heart failure

          -  Chronic kidney disease,

          -  Diabetes with insulin use

          -  History of a cardiovascular event

          -  Pregnant or nursing

          -  Current use of continuous positive airway pressure

          -  Shift work

          -  A known circadian rhythm disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>48 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Calhoun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2017</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>David Calhoun</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>nocturnal hypertension</keyword>
  <keyword>non-dipping blood pressure</keyword>
  <keyword>obstructive sleep apnea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

